- Narrative Type
| - Narrative Text
|
| Additional Text | Please refer to the attached documents:-
(1) Circular to Shareholders dated 6 November 2023;
(2) Notice of Extraordinary General Meeting dated 6 November 2023;
(3) Proxy Form; and
(4) Request Form. |
| Additional Text | This announcement has been prepared by Biolidics Limited (the "Company") and has been reviewed by the Company's sponsor, United Overseas Bank Limited (the "Sponsor"), for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist. |
| Additional Text | This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. |
| Additional Text | The contact person for the Sponsor is Mr. Lim Hoon Khiat, Senior Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898. |